After long haul, cancer bill passes
A bipartisan cancer research bill—aimed at tackling the disease's most dangerous forms—has finally passed Congress after nearly six years of work. The Recalcitrant Cancer Research Act passed both chambers last week as part of the conference report on defense authorization bill. The bill will create scientific frameworks for addressing the most dangerous cancers.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- Proton Beam Therapy Poised for Growth in US